GFM
GILD icon

GF Fund Management’s Gilead Sciences GILD Stock Holding History

GF Fund Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.9M Sell
308,052
-5,026
-2% -$704K 0.72% 31
2025
Q4 		$38.4M Buy
313,078
+14,531
+5% +$1.77M 0.66% 33
2025
Q3 		$33.1M Sell
298,547
-1,455
-0.5% -$165K 0.6% 39
2025
Q2 		$33.3M Buy
300,002
+7,162
+2% +$762K 0.67% 31
2025
Q1 		$32.8M Buy
292,840
+8,484
+3% +$875K 0.77% 29
2024
Q4 		$26.3M Buy
+284,356
New +$25.6M 0.57% 35

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

GF Fund Management's GILD Position: Q1 2026 in Review

GF Fund Management reduced its Gilead Sciences (GILD) stake by 1.6% in Q1 2026, selling an estimated $704K and leaving 308,052 shares worth $42.9M. The position accounts for 0.72% of the portfolio, ranked #31.

GF Fund Management first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • GF Fund Management held 308,052 shares of Gilead Sciences worth $42.9M as of Q1 2026.
  • GF Fund Management sold 5,026 Gilead Sciences shares in Q1 2026, an estimated $704K.
  • Gilead Sciences made up 0.72% of GF Fund Management's portfolio in Q1 2026, its #31 holding.
  • GF Fund Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.